ImmunityBio, Inc. (IBRX)
$8.09-$0.31 (-3.65%) Today
Latest IBRX Insider Trades
Cheryl Cohen - Director
Cheryl Cohen - Director
Barry J. Simon - DirectorBarry J. Simon - DirectorBarry J. Simon - DirectorImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 435,443 | $3.92M |
| Grant or award | 6 | 393,600 | |
| Option exercise | 16 | 624,358 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
28 Form 4 filings on record, the earliest from Dec 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cheryl Cohen - Director | Option exercise | Common Stock | 55,979 | $2.98 | $167K | |
| Cheryl Cohen - Director | Option exercise | Stock Option (right to buy) | 55,979 | $0.00 | - | |
| Cheryl Cohen - Director | Open-market sale | Common Stock | 131,210 | $9.50 | $1.25M | |
| Christobel Selecky - Director | Option exercise | Common Stock | 35,064 | $2.98 | $104K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 124,414 | $2.99 | $372K | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 35,064 | $0.00 | - | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 124,414 | $0.00 | - | |
| Christobel Selecky - Director | Open-market sale | Common Stock | 159,478 | $9.02 | $1.44M | |
| Christobel Selecky - Director | Option exercise | Common Stock | 32,173 | $2.98 | $96K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 33,549 | $2.99 | $100K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 30,000 | $2.84 | $85K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 700 | $2.98 | $2K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 300 | $2.99 | $897 | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 32,173 | $0.00 | - | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 33,549 | $0.00 | - | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 700 | $0.00 | - | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 300 | $0.00 | - | |
| Christobel Selecky - Director | Open-market sale | Common Stock | 95,722 | $9.01 | $862K | |
| Christobel Selecky - Director | Open-market sale | Common Stock | 1,000 | $9.00 | $9K | |
| Barry J. Simon - Director | Open-market sale | Common Stock | 25,000 | $7.88 | $197K | |
| Michael D. Blaszyk - Director | Grant or award | Stock Option (right to buy) | 65,600 | $0.00 | - | |
| Bruce Wendel - Director | Grant or award | Stock Option (right to buy) | 65,600 | $0.00 | - | |
 Linda Maxwell - Director | Grant or award | Stock Option (right to buy) | 65,600 | $0.00 | - | |
| Wesley Clark - Director | Grant or award | Stock Option (right to buy) | 65,600 | $0.00 | - | |
| Cheryl Cohen - Director | Grant or award | Stock Option (right to buy) | 65,600 | $0.00 | - | |
| Christobel Selecky - Director | Grant or award | Stock Option (right to buy) | 65,600 | $0.00 | - | |
| Barry J. Simon - Director | Open-market sale | Common Stock | 23,033 | $7.18 | $165K | |
| Patrick Soon-Shiong - Officer | Other | Common Stock | 4,606,596 | $5.43 | $25.00M | |
| Patrick Soon-Shiong - Officer | Other | Second Amended and Restated Convertible Promissory Note | 0 | $0.00 | - | |
| Barry J. Simon - Director | Open-market sale | Common Stock | 75,000 | $12.01 | $901K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 25,000 | $2.98 | $75K | |
| Christobel Selecky - Director | Open-market sale | Common Stock | 25,000 | $10.00 | $250K | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| David C. Sachs - Officer | Option exercise | Common Stock | 40,650 | $0.00 | - | |
| David C. Sachs - Officer | Tax withholding / forfeiture | Common Stock | 20,682 | $8.70 | $180K | |
| David C. Sachs - Officer | Option exercise | Restricted Stock Units | 40,650 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Option exercise | Common Stock | 114,329 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Tax withholding / forfeiture | Common Stock | 58,170 | $8.70 | $506K | |
| Patrick Soon-Shiong - Officer | Option exercise | Restricted Stock Units | 114,329 | $0.00 | - | |
| Regan J. Lauer - Officer | Option exercise | Common Stock | 4,065 | $0.00 | - | |
| Regan J. Lauer - Officer | Tax withholding / forfeiture | Common Stock | 1,673 | $8.70 | $15K | |
| Regan J. Lauer - Officer | Option exercise | Restricted Stock Units | 4,065 | $0.00 | - | |
| Richard Adcock - Officer | Option exercise | Common Stock | 152,439 | $0.00 | - | |
| Richard Adcock - Officer | Tax withholding / forfeiture | Common Stock | 77,560 | $8.70 | $675K | |
| Richard Adcock - Officer | Option exercise | Restricted Stock Units | 152,439 | $0.00 | - | |
| Barry J. Simon - Director | Open-market sale | Common Stock | 10,000 | $9.25 | $93K | |
| Barry J. Simon - Director | Option exercise | Common Stock | 15,243 | $0.00 | - | |
| Barry J. Simon - Director | Tax withholding / forfeiture | Common Stock | 6,026 | $8.70 | $52K | |
| Barry J. Simon - Director | Open-market sale | Common Stock | 165,000 | $10.25 | $1.69M | |
| Barry J. Simon - Director | Option exercise | Restricted Stock Units | 15,243 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Option exercise | Common Stock | 274,122 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Tax withholding / forfeiture | Common Stock | 118,560 | $6.93 | $822K | |
| Patrick Soon-Shiong - Officer | Option exercise | Restricted Stock Units | 274,122 | $0.00 | - | |
| David C. Sachs - Officer | Option exercise | Common Stock | 82,236 | $0.00 | - | |
| David C. Sachs - Officer | Tax withholding / forfeiture | Common Stock | 42,643 | $6.93 | $296K | |
| David C. Sachs - Officer | Option exercise | Restricted Stock Units | 82,236 | $0.00 | - | |
| Regan J. Lauer - Officer | Option exercise | Common Stock | 5,482 | $0.00 | - | |
| Regan J. Lauer - Officer | Tax withholding / forfeiture | Common Stock | 2,257 | $6.93 | $16K | |
| Regan J. Lauer - Officer | Option exercise | Restricted Stock Units | 5,482 | $0.00 | - | |
| Richard Adcock - Officer | Option exercise | Common Stock | 274,122 | $0.00 | - | |
| Richard Adcock - Officer | Tax withholding / forfeiture | Common Stock | 140,048 | $6.93 | $971K | |
| Richard Adcock - Officer | Option exercise | Restricted Stock Units | 274,122 | $0.00 | - | |
| Barry J. Simon - Director | Open-market sale | Common Stock | 76,967 | $6.54 | $503K | |
| Barry J. Simon - Director | Open-market sale | Common Stock | 75,000 | $7.88 | $591K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 50,000 | $2.98 | $149K | |
| Christobel Selecky - Director | Option exercise | Common Stock | 25,000 | $2.98 | $75K | |
| Christobel Selecky - Director | Open-market sale | Common Stock | 50,000 | $5.00 | $250K | |
| Christobel Selecky - Director | Open-market sale | Common Stock | 25,000 | $7.51 | $188K | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Christobel Selecky - Director | Option exercise | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Bruce Wendel - Director | Grant or award | Stock Option (right to buy) | 146,020 | $0.00 | - | |
| Regan J. Lauer - Officer | Option exercise | Common Stock | 21,031 | $0.00 | - | |
| Regan J. Lauer - Officer | Tax withholding / forfeiture | Common Stock | 7,503 | $2.87 | $22K | |
| Regan J. Lauer - Officer | Option exercise | Restricted Stock Units | 21,031 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Other | Common Stock | 103,710,088 | $1.94 | $200.68M | |
| Patrick Soon-Shiong - Officer | Other | Common Stock | 13,475,172 | $2.28 | $30.72M | |
| Patrick Soon-Shiong - Officer | Other | Convertible Promissory Note | 0 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Other | Convertible Promissory Note | 0 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Other | Amended and Restated Promissory Note | 0 | $0.00 | - | |
| Patrick Soon-Shiong - Officer | Other | Second Amended and Restated Convertible Promissory Note | 0 | $505,000,000.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR | |
| - | - | - | - | View on EDGAR |
ImmunityBio, Inc. (IBRX) had 11 insider filings in the last 90 days, with the most recent on 2026-07-07. The full record for IBRX runs to 28 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of IBRX were filed in the last 90 days.
6 insider sales of IBRX were filed in the last 90 days, totaling $3.92M.
This page tracks IBRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add IBRX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
